Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Communication with share holders
View:
Post by jeffm34 on Jan 26, 2021 11:18am

Communication with share holders

SPCEO1 has the company ever reached out to you prior to or after the financing ?  Have you requested some answers from them ?
Comment by SPCEO1 on Jan 26, 2021 1:38pm
I spoke with the CFO shortly after the deal was announced. I probably was unable to hear much of anything he might have been saying to me as I was aghast at what I had just read. He also was not saying much as he knew I would be very upset. I applaud him for even answering the phone. The conversation was professional but tense, as you can imagine I have not attempted to speak to them since and ...more  
Comment by Wino115 on Jan 26, 2021 2:43pm
Yes, I would say you still have a few levels to go, but you're getting there...like the giraffe. I wonder, does everyone here think that a head should roll if they ultimately conur with this analysis that the deal was sweet for 3 firms and a big stinker for everyone else? Sure looks to be a lot of value destruction so far.  [/quote]
Comment by palinc2000 on Jan 26, 2021 3:20pm
The pernicious effect of including   warrants in Units sold  to retail buyers had to  be known by Dubuc......This explains the trading since the Offering ,,,,The good part is the volume is declining so the number of Unit Buyers interested in just     keeping the warrant  at a very low cost seem to be close to ending,,,,I expext though there will be another ...more  
Comment by Wino115 on Jan 26, 2021 6:15pm
I think they now should see why we all are upset with this deal.  Instead of using the huge positive developments and a future offering to build up solid long-term demand for the shares via a new investment audience created in US and Canada, it's done nothing but create no new demand and a lot of new selling pressure. They need a Board member who is saavy and clever about dealing with ...more  
Comment by Lee430 on Jan 26, 2021 8:12pm
On the surface that connection between Dubuc and NBF appears to be at least questionable with this deal…. I try to only engage counsel as a last resort, however, this does seem like a time to consider it if only to put our minds at rest that nothing inappropriate happened behind the scenes here, or potentially a worse revelation that the people in place here will continue to make poor financial ...more  
Comment by scarlet1967 on Jan 26, 2021 9:01pm
Doesn't exist not only with shareholders but the markets, lack of transparency and and a solid straightforward communication only hurt the stock, their shareholders and make this company less reliable as an investment.
Comment by scarlet1967 on Jan 27, 2021 11:12am
This is how CYDY handle the market, note they will be answering questions from analysts and investors, transparent and informative. "Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities:   1) BLA/MAA submissions to Health Canada, MHRA, EMA, and US FDA 2) HIV prevention ...more  
Comment by scarlet1967 on Jan 27, 2021 11:24am
Potential timeline for submission, potential revenue, potential timeline for program's analysis of interim data.., No wonder they are followed by huge amount of investors. It's hard not to be followed when they frequently update the marker, nobody goes to jail by being transparent and feed their investors with the company's progress step by step.
Comment by jeffm34 on Jan 27, 2021 12:22pm
Can you imagine TH taking questions and comments from ordinary investors right now. Wishful thinking but will never happen with this company even if things are good.   
Comment by scarlet1967 on Jan 27, 2021 12:40pm
I did suggest that among other things to Leah, point is they are doing the exact opposite other well valued companies are doing and the results are the exact opposite, a undervalued company.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities